Doxazosin for benign prostatic obstruction

Research output: Contribution to journalArticlepeer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.

Original languageEnglish (US)
Article numberCD003714
JournalCochrane Database of Systematic Reviews
Volume2013
Issue number6
DOIs
StatePublished - Jun 29 2013

Fingerprint Dive into the research topics of 'Doxazosin for benign prostatic obstruction'. Together they form a unique fingerprint.

Cite this